Clinical significance of endothelial dysfunction in essential hypertension. Curr Hypertens Rep 2015 Nov;17(11):85.
Endothelial dysfunction and hypertension. Adv Exp Med Biol 2017;956:511-540.
Regulatory functions of the vascular endothelium. N Engl J Med 1990 Jul;323(1):27-36.
Abnormal endothelium-dependent vascular relaxation in patients with essential hypertension. N Engl J Med 1990 Jul;323(1):22-27.
Nitric oxide activity in the atherosclerotic human coronary circulation. J Am Coll Cardiol 1997 Feb;29(2):308-317.
Endothelial dysfunction and hypertension: cause or effect? Hypertension 2010 May;55(5):1092-1094.
The regulation and pharmacology of endothelial nitric oxide synthase. Annu Rev Pharmacol Toxicol 2006;46:235-276.
Essential role of endothelial nitric oxide synthase for mobilization of stem and progenitor cells. Nat Med 2003 Nov;9(11):1370-1376.
Nitric oxide activity in the human coronary circulation. Impact of risk factors for coronary atherosclerosis. J Clin Invest 1995 Apr;95(4):1747-1755.
Contribution of nitric oxide to metabolic coronary vasodilation in the human heart. Circulation 1995 Aug;92(3):320-326.
Indirect evidence for release of endothelium-derived relaxing factor in human forearm circulation in vivo. Blunted response in essential hypertension. Circulation 1990 Jun;81(6):1762-1767.
Impaired endothelium-dependent vasodilation in patients with essential hypertension. Evidence that nitric oxide abnormality is not localized to a single signal transduction pathway. Circulation 1995 Mar;91(6):1732-1738.
Selective loss of microvascular endothelial function in human hypercholesterolemia. Circulation 1994 Jul;90(1):35-41.
Effects of estrogen replacement therapy on peripheral vasomotor function in postmenopausal women. Am J Cardiol 1995 Feb;75(4):264-268.
Evidence that endothelial dysfunction in patients with hypercholesterolemia is not due to increased extracellular nitric oxide breakdown by superoxide anions. Am J Cardiol 1995 Dec;76(16):1157-1161.
Selective defect in nitric oxide synthesis may explain the impaired endothelium-dependent vasodilation in patients with essential hypertension. Circulation 1998 Mar;97(9):851-856.
Decreased vasodilator response to isoproterenol during nitric oxide inhibition in humans. Hypertension 1997 Oct;30(4):918-921.
Role of nitric oxide in the vasodilator response to mental stress in normal subjects. Am J Cardiol 1997 Oct;80(8):1070-1074.
Increased activity of endogenous endothelin in hypercholesterolemic patients. Circulation 1997;96(8): 1395-1395.
Xanthine oxidase inhibition with oxypurinol improves endothelial vasodilator function in hypercholesterolemic but not in hypertensive patients. Hypertension 1997 Jul;30(1 Pt 1):57-63.
Close relation of endothelial function in the human coronary and peripheral circulations. J Am Coll Cardiol 1995 Nov;26(5):1235-1241.
Prognostic value of flow-mediated vasodilation in brachial artery and fingertip artery for cardiovascular events: a systematic review and meta-analysis. J Am Heart Assoc 2015 Nov;4(11):e002270.
Non-invasive endothelial function testing and the risk of adverse outcomes: a systematic review and meta-analysis. Eur Heart J Cardiovasc Imaging 2014 Jul;15(7):736-746.
Predictive value of brachial flow-mediated dilation for incident cardiovascular events in a population-based study: the multi-ethnic study of atherosclerosis. Circulation 2009 Aug;120(6):502-509.
Prognostic role of flow-mediated dilation and cardiac risk factors in post-menopausal women. J Am Coll Cardiol 2008 Mar;51(10):997-1002.
Brachial flow-mediated dilation predicts incident cardiovascular events in older adults: the Cardiovascular Health Study. Circulation 2007 May;115(18):2390-2397.
Predictive value of endothelial function by noninvasive peripheral arterial tonometry for coronary artery disease. Coron Artery Dis 2015 May;26(3):231-238.
Transient hypertension directly impairs endothelium-dependent vasodilation of the human microvasculature. Hypertension 2000 Dec;36(6):941-944.
Elevated blood pressure in adolescent boys predicts endothelial dysfunction: the cardiovascular risk in young Finns study. Hypertension 2006 Sep;48(3):424-430.
Activation of endothelial L-arginine pathway in resistance arteries. Effect of age and hypertension. Hypertension 1990 Aug;16(2):170-179.
Endothelial dysfunction and the risk of hypertension: the multi-ethnic study of atherosclerosis. Hypertension 2010 May;55(5):1210-1216.
Preserved endothelium-dependent vasodilatation in patients with essential hypertension. N Engl J Med 1994 Apr;330(15):1036-1040.
Role of endothelium-derived nitric oxide in the abnormal endothelium-dependent vascular relaxation of patients with essential hypertension. Circulation 1993 May;87(5):1468-1474.
; Murrow, J.; Kavtaradze, N.; Sheikh, A.; Jorgensen, J.; Pohel, K.; Manatunga, A.; Quyyumi, A. The contribution of endothelial-derived hyperpolarising factor and nitric oxide to basal and stimulatory vasodilator tone in metabolic syndrome. Paper presented at: Annual Scientific Conference of the British-Cardiovascular-Society; Jun 02-04, 2008. Manchester, England.
Interactions between nitric oxide and endothelin in the regulation of vascular tone of human resistance vessels in vivo. Hypertension 2000 Jun;35(6):1237-1241.
Improved endothelium-dependent vasodilation after block-ade of endothelin receptors in patients with essential hypertension. Circulation 2002 Jan;105(4):452-456.
Ethnic differences in the vasoconstrictor activity of endogenous endothelin-1 in hypertensive patients. Circulation 2004 Jun;109(25):3191-3195.
Nitric oxide dysfunction in vascular endothelium and platelets: role in essential hypertension. J Hypertens 2009 Dec;27(12):2310-2320.
A large blood pressure-raising effect of nitric oxide synthase inhibition in humans. Hypertension 1999 Apr;33(4):937-942.
The T-786-C mutation in endothelial nitric oxide synthase is associated with hypertension. Hypertension 2002 Apr;39(4):919-922.
Defective L-arginine-nitric oxide pathway in off-spring of essential hypertensive patients. Circulation 1996 Sep;94(6):1298-1303.
Endothelial dysfunction and the risk of hypertension: the multi-ethnic study of atherosclerosis. Hypertension 2010 May;55(5):1210-1216.
CDC/AHA workshop on markers of inflammation and cardiovascular disease: application to clinical and public health practice: report from the clinical practice discussion group. Circulation 2004 Dec;110(25):e550-e553.
Asymmetric dimethylarginine, L-arginine, and endothelial dysfunction in essential hypertension. J Am Coll Cardiol 2005 Aug;46(3):518-523.
Association between asymmetric dimethylarginine and indices of vascular function in patients with essential hypertension. Blood Press 2011 Apr;20(2):111-116.
Asymmetric dimethylarginine (ADMA) has a role in regulating systemic vascular tone in young healthy subjects: the cardiovascular risk in young Finns study. Am J Hypertens 2008 Aug;21(8):873-878.
The association between biomarker profiles, etiology of chronic kidney disease, and mortality. Am J Nephrol 2017 Feb;45(3):226-234.
Asymmetric dimethylarginine and cardiovascular risk: systematic review and meta-analysis of 22 prospective studies. J Am Heart Assoc 2015 May;4(6):e001833.
Levels of asymmetric dimethylarginine (ADMA), an endogenous nitric oxide synthase inhibitor, and risk of coronary artery disease: a meta-analysis based on 4713 participants. Eur J Prev Cardiol 2016 Mar;23(5):502-510.
Role of oxidative stress in atherosclerosis. Am J Cardiol 2003 Feb;91(3A):7A-11A.
Radical-free biology of oxidative stress. Am J Physiol Cell Physiol 2008 Oct;295(4):C849-C868.
Thiol/disulfide redox states in signaling and sensing. Crit Rev Biochem Mol Biol 2013 Mar-Apr;48(2):173-181.
Measuring the poise of thiol/disulfide couples in vivo. Free Radic Biol Med 2009 Nov;47(10):1329-1338.
The relationship between plasma levels of oxidized and reduced thiols and early atherosclerosis in healthy adults. J Am Coll Cardiol 2006 Mar;47(5):1005-1011.
Oxidative stress is associated with impaired arterial elasticity. Atherosclerosis 2011 Sep;218(1):90-95.
Intracellular proatherogenic events and cell adhesion modulated by extracellular thiol/disulfide redox state. Circulation 2005 Jun;111(22):2973-2980.
Glutathione and thioredoxin redox during differentiation in human colon epithelial (Caco-2) cells. Am J Physiol Gas-trointest Liver Physiol 2002 Dec;283(6):G1352-G1359.
The plasma redox state and ageing. Ageing Res Rev 2002 Apr;1(2):257-278.
Glutathione in human plasma: decline in association with aging, age-related macular degeneration, and diabetes. Free Radic Biol Med 1998 Mar;24(5):699-704.
Plasma glutathione redox state: a novel marker of oxidative stress, correlates with early atherosclerosis in humans. J Am Coll Cardiol 2003;41(Suppl A):293A-294A.
Oxidative stress is associated with increased pulmonary artery systolic pressure in humans. Hypertension 2014 Jun;63(6):1270-1275.
Circulating endothelial progenitor cells, vascular function, and cardiovascular risk. N Engl J Med 2003 Feb;348(7):593-600.
Isolation of putative progenitor endothelial cells for angiogenesis. Science 1997 Feb;275(5302):964-967.
Origins of circulating endothelial cells and endothelial outgrowth from blood. J Clin Invest 2000 Jan;105(1):71-77.
Endothelial function in health and disease: new insights into the genesis of cardiovascular disease. Am J Med 1998 Jul;105(1A):32S-39S.
Endothelial progenitor cells: characterization and role in vascular biology. Circ Res 2004 Aug;95(4):343-353.
Endothelial progenitor cells functional characterization. Trends Cardiovasc Med 2004 Nov;14(8):318-322.
VEGF gene delivery to muscle: potential role for vasculogenesis in adults. Mol Cell 1998 Nov;2(5):549-558.
Stem cell therapy and gene transfer for regeneration. Gene Ther 2000 Mar;7(6):451-457.
Stimulation of endothelial progenitor cells with granulocyte-macrophage colony stimulating factor improves endothelial dysfunction in patients with peripheral arterial disease. J Am Coll Cardiol 2006 Feb;47(4):A381-A384.
Endothelial cells of hematopoietic origin make a significant contribution to adult blood vessel formation. Circ Res 2000 Oct;87(9):728-730.
Regeneration of ischemic cardiac muscle and vascular endothelium by adult stem cells. J Clin Invest 2001 Jun;107(11):1395-1402.
Neovascularization of ischemic myocardium by human bone-marrow-derived angioblasts prevents cardiomyocyte apoptosis, reduces remodeling and improves cardiac function. Nat Med 2001 Apr;7(4):430-436.
Determination of bone marrow-derived endothelial progenitor cell significance in angiogenic growth factor-induced neovascularization in vivo. Exp Hematol 2002 Aug;30(8):967-972.
Expression of VEGFR-2 and AC133 by circulating human CD34+ cells identifies a population of functional endothelial precursors. Blood 2000 Feb;95(3):952-958.
Bone marrow monocyte lineage cells adhere on injured endothelium in a monocyte chemoattractant protein-1-dependent manner and accelerate reendothelialization as endothelial progenitor cells. Circ Res 2003 Nov;93(10):980-989.
Isolation and transplantation of autologous circulating endothelial cells into denuded vessels and prosthetic grafts: implications for cell-based vascular therapy. Circulation 2003 Nov;108(21):2710-2715.
Bone marrow-derived progenitor cells modulate vascular reendothelialization and neointimal formation: effect of 3-hydroxy-3-methylglutaryl coenzyme a reductase inhibition. Arterioscler Thromb Vasc Biol 2002 Oct;22(10):1567-1572.
Aging, progenitor cell exhaustion, and atherosclerosis. Circulation 2003 Jul;108(4):457-463.
Evidence from a leukaemia model for maintenance of vascular endothelium by bone-marrow-derived endothelial cells. Lancet 2000 May;355(9216):1688-1691.
Endothelial progenitor cells: current development of their paracrine factors in cardiovascular therapy. J Cardiovasc Pharmacol 2012 Apr;59(4):387-396.
Stem and progenitor cells for neurological repair: minor issues, major hurdles, and exciting opportunities for paracrine-based therapeutics. J Cell Biochem 2011 Feb;112(2):374-380.
Impaired progenitor cell activity in age-related endothelial dysfunction. J Am Coll Cardiol 2005 May;45(9):1441-1448.
Age-dependent depression in circulating endothelial progenitor cells in patients undergoing coronary artery bypass grafting. J Am Coll Cardiol 2003 Dec;42(12):2073-2080.
Increase in circulating endothelial progenitor cells by statin therapy in patients with stable coronary artery disease. Circulation 2001 Jun;103(24):2885-2890.
Infarct remodeling after intracoronary progenitor cell treatment in patients with acute myocardial infarction (TOPCARE-AMI): mechanistic insights from serial contrast-enhanced magnetic resonance imaging. Circulation 2003 Nov;108(18):2212-2218.
Human endothelial progenitor cells from type II diabetics exhibit impaired proliferation, adhesion, and incorporation into vascular structures. Circulation 2002 Nov;106(22):2781-2786.
Endothelial progenitor cells during cerebrovascular disease. Stroke 2005 Jan;36(1):151-153.
Reduced number of circulating endothelial progenitor cells predicts future cardiovascular events: proof of concept for the clinical importance of endogenous vascular repair. Circulation 2005 Jun;111(22):2981-2987.
Circulating endothelial progenitor cells and cardiovascular outcomes. N Engl J Med 2005 Sep;353(10):999-1007.
Low CD34+ cell count and metabolic syndrome synergistically increase the risk of adverse outcomes. Atherosclerosis 2009 Nov;207(1):213-219.
The nature and significance of platelet products in human plasma. Br J Haematol 1967 May;13(3):269-288.
Association of circulating endothelial microparticles with cardiometabolic risk factors in the Framingham Heart Study. Eur Heart J 2014 Nov;35(42):2972-2979.
Role of microparticles in endothelial dysfunction and arterial hypertension. World J Cardiol 2014 Nov;6(11):1135-1139.
Endothelial microparticle formation by angiotensin II is mediated via Ang II receptor type I/NADPH oxidase/Rho kinase pathways targeted to lipid rafts. Arterioscler Thromb Vasc Biol 2011 Aug;31(8):1898-1907.
Circulating microparticles from patients with myocardial infarction cause endothelial dysfunction. Circulation 2001 Nov;104(22):2649-2652.
Effects of severe hypertension on endothelial and platelet microparticles. Hypertension 2003 Feb;41(2):211-217.
Berberine-induced decline in circulating CD31+/CD42-microparticles is associated with improvement of endothelial function in humans. Eur J Pharmacol 2009 Jul;614(1-3): 77-83.
The assessment of endothelial function: from research into clinical practice. Circulation 2012 Aug;126(6):753-767.
Effects of an angiotensin II receptor blocker on the impaired function of endothelial progenitor cells in patients with essential hypertension. Am J Hypertens 2014 May;27(5):695-701.
Effects of nebivolol or irbesartan in combination with hydrochlorothiazide on vascular functions in newly-diagnosed hypertensive patients: the NINFE (Nebivololo, Irbesartan Nella Funzione Endoteliale) study. Int J Cardiol 2012 Mar;155(2):279-284.
Angiotensin converting enzyme inhibitors effect on endothelial dysfunction: a meta-analysis of randomised controlled trials. Atherosclerosis 2011 May;216(1):7-16.
The effects of amlodipine and S(-)-amlodipine on vascular endothelial function in patients with hypertension. Am J Hypertens 2014 Jan;27(1):27-31.
Tetrahydro-biopterin: a novel antihypertensive therapy. J Hum Hypertens 2008 Jun;22(6):401-407.